Industry Calls For Canadian Pricing Guideline Consultation To Be Suspended
IMC, the R&D-based pharmaceutical industry association in Canada, says the guideline will “exacerbate an already unpredictable regulatory environment.”
You may also be interested in...
The implementation of new pricing guidelines that are unpopular with the pharmaceutical has been put on hold, to the relief of the pharmaceutical industry.
New draft guidelines outlining how Canada’s drug pricing authority will decide whether to investigate if a medicine is excessively priced are now out for consultation.
Some measures aimed at reducing medicine prices in Canada have been dropped, to the relief of the pharmaceutical industry.